Rapid screening of industrial compounds for toxicity will require high-throughput in vitro assays with which to select candidate compounds for more intensive animal testing. The purpose of this study, sponsored by the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM) and the European Centre for the Validation of Alternative Methods (ECVAM), is to evaluate the utility of in vitro cytotoxicity assays for estimating the starting dose for the rat oral acute toxicity test, thus reducing and refining the use of animals in the toxicological assessment of industrial chemicals of military interest. The three-phase study will evaluate 72 coded chemicals with well-defined in vivo acute tox...
The implementation of Registration, Evaluation and Authorisation of new and existing Chemicals (REAC...
In vitro cytotoxicity tests are typically carried out with transformed, immortalized cell lines or p...
The question of whther, and if so, to what extent, non-animal tests or testing strategies could sign...
In vitro cytotoxicity assays can be used as alternative toxicity tests to reduce the total number of...
From a regulatory point of view, the main objective of acute toxicity testing is toclassify chemical...
The FRAME KB cytotoxicity assay is an ill vitro test for basal cytotoxicity which measures the sub-l...
Future EU legislations enforce a fast hazard and risk assessment of thousands of existing chemicals....
Prior to introduction to the clinic, pharmaceuticals must undergo rigorous toxicity testing to ensur...
Prior to introduction to the clinic, pharmaceuticals must undergo rigorous toxicity testing to ensur...
Prior to introduction to the clinic, pharmaceuticals must undergo rigorous toxicity testing to ensur...
Prior to introduction to the clinic, pharmaceuticals must undergo rigorous toxicity testing to ensur...
The implementation of Registration, Evaluation and Authorisation of new and existing Chemicals (REAC...
The implementation of REACH (Registration, Evaluation and Authorisation of new and existing Chemical...
The implementation of Registration, Evaluation and Authorisation of new and existing Chemicals (REAC...
The replacement of animals in acute systemic toxicity testing remains a considerable challenge. Only...
The implementation of Registration, Evaluation and Authorisation of new and existing Chemicals (REAC...
In vitro cytotoxicity tests are typically carried out with transformed, immortalized cell lines or p...
The question of whther, and if so, to what extent, non-animal tests or testing strategies could sign...
In vitro cytotoxicity assays can be used as alternative toxicity tests to reduce the total number of...
From a regulatory point of view, the main objective of acute toxicity testing is toclassify chemical...
The FRAME KB cytotoxicity assay is an ill vitro test for basal cytotoxicity which measures the sub-l...
Future EU legislations enforce a fast hazard and risk assessment of thousands of existing chemicals....
Prior to introduction to the clinic, pharmaceuticals must undergo rigorous toxicity testing to ensur...
Prior to introduction to the clinic, pharmaceuticals must undergo rigorous toxicity testing to ensur...
Prior to introduction to the clinic, pharmaceuticals must undergo rigorous toxicity testing to ensur...
Prior to introduction to the clinic, pharmaceuticals must undergo rigorous toxicity testing to ensur...
The implementation of Registration, Evaluation and Authorisation of new and existing Chemicals (REAC...
The implementation of REACH (Registration, Evaluation and Authorisation of new and existing Chemical...
The implementation of Registration, Evaluation and Authorisation of new and existing Chemicals (REAC...
The replacement of animals in acute systemic toxicity testing remains a considerable challenge. Only...
The implementation of Registration, Evaluation and Authorisation of new and existing Chemicals (REAC...
In vitro cytotoxicity tests are typically carried out with transformed, immortalized cell lines or p...
The question of whther, and if so, to what extent, non-animal tests or testing strategies could sign...